Table 1. Patient characteristics.

	FEV1	TLC	DLCOc	Age	sex	treatment for ILD
1	82	65	43	71	m	no
2	54	56	31	49	m	no
3	77	58	36	89	m	no
4	55	69	N/A	84	m	no
5	94.2	82	94.5	61	m	no
6	72.9	76.4	61.8	73	f	no
7	55	75	N/A	55	m	no
8	76.5	68.3	49.7	82	m	no
9	88	66	50	80	m	prednisone
10	54.7	62.5	17.7	51	m	no
11	39.4	35.1	9	59	m	prednisone
12	86.1	75.3	N/A	86	m	no
13	56.2	58.2	33.1	75	m	prednisone
14	51.9	61.5	52.5	55	m	prednisone
15	65.9	55.5	35.5	73	f	study drug
16	50.4	44.1	31.6	61	m	Prednisone study drug
17	43	62.5	47.8	63	m	no
18	59.9	66.5	29.8	58	m	prednisone
19	41.3	48.8	N/A	65	f	prednisone azathioprine
20	53.1	65.7	39.7	73	f	no
21	68.7	83.3	31.7	88	f	no
22	33.7	37.3	17.2	59	m	prednisone cyclophosphamide